IRIS
RICEVUTO, ENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.875
EU - Europa 4.048
AS - Asia 2.918
SA - Sud America 286
AF - Africa 17
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.157
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.849
IE - Irlanda 1.077
CN - Cina 923
SG - Singapore 866
TR - Turchia 682
SE - Svezia 604
DE - Germania 449
IT - Italia 439
RU - Federazione Russa 414
HK - Hong Kong 339
UA - Ucraina 333
GB - Regno Unito 284
BR - Brasile 258
FI - Finlandia 186
FR - Francia 142
CZ - Repubblica Ceca 41
IN - India 28
BE - Belgio 24
VN - Vietnam 24
CA - Canada 14
NL - Olanda 11
IQ - Iraq 10
BD - Bangladesh 9
AT - Austria 7
EC - Ecuador 7
AR - Argentina 6
AU - Australia 6
CL - Cile 6
EU - Europa 6
DM - Dominica 5
ES - Italia 5
KR - Corea 5
MX - Messico 5
PT - Portogallo 5
UZ - Uzbekistan 5
ZA - Sudafrica 5
JO - Giordania 4
MA - Marocco 4
PL - Polonia 4
AZ - Azerbaigian 3
DZ - Algeria 3
JP - Giappone 3
KE - Kenya 3
LU - Lussemburgo 3
NP - Nepal 3
PK - Pakistan 3
RO - Romania 3
RS - Serbia 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CO - Colombia 2
EE - Estonia 2
MD - Moldavia 2
PE - Perù 2
PY - Paraguay 2
SA - Arabia Saudita 2
TN - Tunisia 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
Totale 13.157
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.308
Chandler 1.216
Dublin 1.077
Boardman 410
Singapore 409
Santa Clara 348
Hong Kong 338
Izmir 326
Nanjing 236
Wilmington 194
San Mateo 191
Lawrence 168
Princeton 168
Ann Arbor 164
Ashburn 120
New York 119
Beijing 110
Moscow 98
Nanchang 86
Milan 84
Woodbridge 74
Bremen 61
Seattle 57
Shenyang 56
Tianjin 55
Des Moines 47
Helsinki 46
Hebei 44
L'aquila 43
Verona 43
Brno 40
Kunming 37
Changsha 31
Jiaxing 29
Sant'egidio Alla Vibrata 27
Los Angeles 26
Mountain View 26
Munich 26
Brussels 24
Dong Ket 22
Hangzhou 22
Jinan 22
Shanghai 22
Norwalk 21
São Paulo 21
Dearborn 19
Guangzhou 19
Philadelphia 19
The Dalles 19
Zhengzhou 19
Pune 16
Rome 16
Auburn Hills 15
Council Bluffs 14
Falkenstein 12
Lanzhou 12
Ningbo 12
Pescara 12
Changchun 11
Dallas 11
Falls Church 11
Monza 10
Fremont 8
Fuzhou 8
L’Aquila 8
Taizhou 8
Belo Horizonte 7
Brescia 7
London 7
Redwood City 7
Rio de Janeiro 7
Tappahannock 7
Toronto 7
Berlin 6
Buffalo 6
San Francisco 6
Washington 6
Amsterdam 5
Brasília 5
Frankfurt am Main 5
Istanbul 5
Joinville 5
Melzo 5
Roseau 5
Tashkent 5
Vienna 5
Amman 4
Campinas 4
Clifton 4
Dhaka 4
Düsseldorf 4
Hefei 4
Madrid 4
Ottawa 4
Ribeirão das Neves 4
Vitória da Conquista 4
Baghdad 3
Baotou 3
Campobasso 3
Ciampino 3
Totale 8.541
Salva come PNG Salva come JPEG
Nome #
The supportive care task force at the University of L'Aquila: 2-years experience 148
The prevalent KRAS exon 2 c.35 G > A mutation in metastatic colorectal cancer patients: a biomarker of worse prognosis and potential benefit of bevacizumab-containing intensive regimens? 148
P16 hypermethylation contributes to the characterization of gene inactivation profiles in primary gastric cancer 122
KRAS and Two Rare PI3KCA Mutations Coexisting in a Metastatic Colorectal Cancer Patient With Aggressive and Resistant Disease. 119
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis. 116
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations. 114
Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines 113
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families 113
Mutazioni della p53 in campioni selezionati di adenocarcinoma del colon dell’Italia Centrale 112
Dose-finding study of oxaliplatin associated to capecitabine based preoperative chemoradiotherapy in locally advanced rectal cancer 110
Bone targeted therapy for preventing skeletal-related events in metastatic breast cancer 109
Antiproliferative and pro-apoptotic effects of 5-azacytidine in prostate carcinoma cells in vitro involve the recovering of PTEN-mediated Akt activity control and androgen sensitivity 107
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 107
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro 106
Differential prognosis of metastatic colorectal cancer patients post-progression to first-line triplet chemotherapy plus bevacizumab, Fir-B/FOx, according to seconde-line treatment and KRAS genotype 104
KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy. 104
Bioclinical parameters driving decision-making of subsequent lines of treatment in metastatic castration-resistant prostate cancer 103
Epigenetic modulation of PTEN expression during antiandrogenic therapies in human prostate cancer 103
two simulteneous and very uncommom pi3kca mutations in a liver metastasis from colorectal cancer patient with aggressive and resistant disease 99
Oncology together for L'Aquila: early resumption of integrated oncological activities after the earthquake 99
Dose-dense nonpegylated liposomal doxorubicin and docetaxel combination in breast cancer: Dose-finding study 97
Apoptosis induced by oxaliplatin in human colon cancer HCT15 cell line 97
Axitinib after Sunitinib in metastatic renal cancer: Preliminary results from Italian "Real-World" SAX Study 97
Assessment and treatment of symptoms among italian medical oncologists 96
Pain evaluation and management: a survey of Italian radiotherapists 96
Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer. families 95
Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients 94
Symptoms in advanced cancer: The influence of sex, age, Karnofsky Performance Status and PaP score. 93
Trifluoroibuprofen inhibits α-Methylacyl Coenzyme A Racemase (AMACR/P504S), Reduces Cancer Cell Proliferation and Inhibits in Vivo Tumor Growth in Aggressive Prostate Cancer Models. 92
New schedule of bevacizumab/paclitaxel as first-line therapy for metastatic HER2-negative breast cancer in a real-life setting 92
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models 92
NEW MUTATIONS AND PROTEIC VARIANTS OF NBS1 ARE IDENTIFIED IN CANCER CELL LINES 91
ABERRANT HYPERMETHYLATION OF THE P16 GENE IN SPORADIC GASTRIC CANCER 91
Hypoxic pelvic perfusion with cisplatin and mitomycin C in multidisciplinary palliative treatment of patients with unresectable recurrent rectal cancer: A retrospective study 91
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis 91
Oxaliplatin (l-OHP) association with paclitaxel (PTX) or docetaxel (DTX) in NSCLC cell lines: Schedule-dependent activity based on p53/microtubule associated protein 4 (MAP4) interaction 90
Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx). 90
An association of epirubicin, etoposide and cisplatin in gastric cancer: a phase II study 89
CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models 89
Real-life multidisciplinary treatment for unresectable colorectal cancer liver metastases including hepatic artery infusion with chemo-filtration and liquid biopsy precision oncotherapy: observational cohort study 88
A phase II study of dose-dense epirubicin plus cyclophosphamide followed by docetaxel plus capecitabine and pegfilgrastim support as preoperative therapy for patients with stage II, IIIA breast cancer 87
p16 (INK4a, MTS-1) gene polymorphism and methylation status in human pituitary tumors 87
A KRAS and dual concomitant PI3KCA mutations in a metastatic colorectal cancer patient with aggressive and resistant disease 87
Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cells 87
Gabapentin in the treatment of severe sweating experienced by advanced cancer patients 87
Meccanismo d’azione e farmacologia di nuovi composti organometallici nel trattamento del carcinoma del colon-retto. 86
Prognostic relevance of KRAS genotype and the prevalent C.35 G > a mutation in metastatic colorectal cancer (MCRC) patients fitting for intensive FIr-B/FOx triplet chemotherapy plus bevacizumab 86
A six-gene signature predicting breast cancer lung metastasis 85
Effects of Chemotherapy in Patients with Concomitant Aortic Aneurysm and Malignant Disease 84
Precision oncotherapy based on liquid biopsies in multidisciplinary treatment of unresectable recurrent rectal cancer: a retrospective cohort study 84
Multidisciplinary management of hepatocellular carcinoma in clinical practice 84
Poker association of weekly alternating 5-fluorouracil, irinotecan,bevacizumab and oxaliplatin (FIrB/FOx) in first line treatment of metastatic colorectal cancer: a phase II study 83
Modulation of GemOx chemotherapy according to CIRS in elderly patients with advanced pancreatic cancer 83
Role of estrogen receptor alpha in aggressiveness and osteoclastogenic potential of human breast carcinoma cells. 83
Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma? 83
Hiccup in patients with advanced cancer successfully treated with gabapentin: report of three cases 83
Effects of EGFR tyrosine kinase inhibitor erlotinib in prostate cancer cells in vitro 82
New mutations and protein variants of NBSI are identified in cancer cell lines 82
Medical emergencies in oncology: hypercalcemia. II. Diagnosisand therapy 82
Multidisciplinary palliation for unresectable recurrent rectal cancer: Hypoxic pelvic perfusion with mitomycin C and oxaliplatin in patients progressing after systemic chemotherapy and radiotherapy, a retrospective cohort study 82
Role of immunoscintigraphy in clinical assessment of gastrointestinal tumors 82
Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples. 81
Triplet schedule of weekly 5-fluorouracil and alternating irinotecan or oxaliplatin in advanced colorectal cancer: a dose-finding and phase II study 81
Novel P53 mutations detected by FAMA in colorectal cancers 80
Timed-flat infusion of 5-fluorouracil associated with docetaxel as first-line treatment of patients with metastatic breast cancer 80
Does the search for large genomic rearrangements impact BRCAPRO carrier prediction? 79
Prognostic relevance of PIK3CA mutations in breast cancer patients treated with primary dose-dense epirubicin/cyclophosphamide -> dose-dense docetaxel 79
Plasma proteomic profiling in hereditary breast cancer reveals a BRCA1-specific signature: Diagnostic and functional implications 79
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study 78
Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy 77
Effectiveness of liver metastasectomies in patients with metastatic colorectal cancer treated with FIr-B/FOx triplet chemotherapy plus bevacizumab. 77
Intensive chemotherapy of metastatic colorectal cancer: weighing between safety and clinical efficacy. Evaluation of Masi G, Loupakis F, Salvatore L, et al. Bevaizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial. Lancet Oncol 2010;11:845-52 77
Oxaliplatin:preclinical in vitro studies 77
The adjuvant therapy of colonic carcinoma in old age 76
Carcinoma della vescica 76
Prognosis of gastric cancer by p53 gene mutations from "touch preparations" and PCR/SSCP analysis. 76
Effectiveness and safety of intensive triplet chemotherapy plus bevecizumab, FIr-B/FOx, in young-elderly metastatic colorectal cancer 76
Clinical parameters to guide decision-making in elderly metastatic colorectal CANCER patients treated with intensive cytotoxic and anti-angiogenic therapy 76
Prognostic relevance of KRAS genotype in metastatic colorectal cancer patients unfit for FIr-B/FOx intensive regimen 76
Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study 75
Evaluation of widely used models for predicting BRCA1 and BRCA2 mutations 75
Significato prognostico e predittivo delle alterazioni genetiche nel carcinoma gastrico 75
Valutazioni seriate del peptide natriuretico cerebrale sono predittive di cardiotossicità da antracicline in pazienti sottoposti a chemioterapia non ad alte dosi 75
Choice of chemotherapy schedules in elderly patients (> 75 years) with metastatic colorectal cancer (mcrc) according to comorbidity 75
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation 75
High sensitivity of detectionof TP53 somatic mutations by fluorescence-assisted mismatch analysis 75
Intraperitoneal chemotherapy [LA CHEMIOTERAPIA INTRAPERITONEALE] 74
Triplet Chemotherapy in Patients With Metastatic Colorectal Cancer: Toward the Best Way to Safely Administer a Highly Active Regimen in Clinical Practice 74
Tailoring the dosing schedule of nab-paclitaxel in metastatic breast cancer according to patient and disease characteristics: Recommendations from a panel of experts 74
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives 74
Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6–7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A 74
Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models 73
Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancer 73
In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human cancer cells 73
Home care for cancer patients after an earthquake: the experience of the "L'Aquila per la Vita" Home Care Unit 73
Recidive loco-regionali da carcinoma colo-rettale: risultati a breve termine della perfusione pelvica ipossica. 73
Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama 72
From adjuvant to preventive breast cancer treatment: bridging the gap over troubled waters 72
Familiarity and heredity of tumors in function of an early surgical therapeutic approach 72
Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients 72
Totale 8.825
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.427
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.427
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020186 0 0 0 0 0 0 0 0 0 0 7 179
2020/20211.451 20 173 8 178 190 70 186 10 178 68 283 87
2021/20221.110 67 88 276 73 32 18 12 55 66 21 76 326
2022/20233.321 233 205 61 358 346 378 5 212 1.375 13 78 57
2023/2024717 116 44 33 103 50 178 16 63 0 28 27 59
2024/20252.843 97 73 308 134 439 268 469 286 678 83 8 0
Totale 13.399